Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
32,413.81
26,450.47
25,090.90
17,748.48
15,110.55
14,561.08
15,658.68
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
32,413.81
26,450.47
25,090.90
17,748.48
15,110.55
14,561.08
15,658.68
Raw Material Cost
15,842.83
12,429.26
12,268.91
8,220.14
7,706.41
7,093.31
9,694.35
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
202.75
138.78
125.06
126.65
184.86
235.01
377.80
Selling and Distribution Expenses
11,368.07
8,117.65
6,893.69
4,907.65
4,482.36
4,838.67
4,864.81
Other Expenses
201.49
160.24
55.80
29.84
20.74
16.58
-3.80
Total Expenditure (Excl Depreciation)
29,428.59
22,288.11
19,845.67
13,552.87
12,581.01
12,332.83
14,898.98
Operating Profit (PBDIT) excl Other Income
2985.2
4162.4
5245.2
4195.6
2529.5
2228.3
759.7
Other Income
3,461.57
2,942.55
4,095.71
4,053.86
2,587.52
774.73
1,579.37
Operating Profit (PBDIT)
9,057.87
8,972.90
10,941.42
9,426.90
6,304.74
4,232.14
3,700.68
Interest
202.75
138.78
125.06
126.65
184.86
235.01
377.80
Exceptional Items
-230.94
8.31
-1,456.27
60.49
-756.63
294.69
-310.57
Gross Profit (PBDT)
16,570.97
14,021.21
12,821.99
9,528.34
7,404.14
7,467.77
5,964.33
Depreciation
2,611.09
1,867.98
1,600.47
1,177.43
1,187.68
1,229.15
1,361.61
Profit Before Tax
6,013.10
6,974.44
7,759.61
8,183.31
4,175.56
3,062.67
1,650.70
Tax
1,148.51
1,456.74
1,708.90
1,016.21
497.79
414.54
-308.09
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
4,924.85
5,531.26
6,060.06
7,127.63
3,661.86
2,550.38
1,950.31
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
4,924.85
5,531.26
6,060.06
7,127.63
3,661.86
2,550.38
1,950.31
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-60.26
-13.55
-9.35
39.48
15.92
97.75
8.48
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
4,864.59
5,517.71
6,050.71
7,167.10
3,677.77
2,648.13
1,958.79
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
40,022.74
34,114.42
26,211.83
19,561.09
15,734.45
16,288.07
28,408.99
Earnings per share (EPS)
118.3
132.86
145.57
171.21
87.96
61.26
46.85
Diluted Earnings per share
118.3
132.86
145.57
171.21
87.96
61.26
46.85
Operating Profit Margin (Excl OI)
9.21%
15.74%
20.9%
23.64%
16.74%
15.3%
4.85%
Gross Profit Margin
26.61%
33.43%
37.3%
52.74%
35.49%
29.47%
19.24%
PAT Margin
15.19%
20.91%
24.15%
40.16%
24.23%
17.52%
12.46%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 22.55% vs 5.42% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is -11.84% vs -8.81% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -7.20% vs -11.91% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 46.04% vs 10.95% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has fallen from Mar 2024
Compare Annual Results Of Shin Nippon Biomedical Laboratories, Ltd. With
Figures in Million
Consolidate Annual Results
Change(JPY)
Change(%)
Net Sales
32,413.81
1,15,362.00
-82,948.19
-71.90%
Other Operating Income
0.00
0.00
0.00
Total Operating income
32,413.81
1,15,362.00
-82,948.19
-71.90%
Raw Material Cost
15,842.83
88,232.00
-72,389.17
-82.04%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
202.75
14.00
188.75
1,348.21%
Selling and Distribution Expenses
11,368.07
18,358.00
-6,989.93
-38.08%
Other Expenses
201.49
169.60
31.89
18.80%
Total Expenditure (Excl Depreciation)
29,428.59
1,08,300.00
-78,871.41
-72.83%
Operating Profit (PBDIT) excl Other Income
2,985.22
7,062.00
-4,076.78
-57.73%
Other Income
3,461.57
1,233.00
2,228.57
180.74%
Operating Profit (PBDIT)
9,057.87
12,044.00
-2,986.13
-24.79%
Interest
202.75
14.00
188.75
1,348.21%
Exceptional Items
-230.94
-298.00
67.06
22.50%
Gross Profit (PBDT)
16,570.97
27,130.00
-10,559.03
-38.92%
Depreciation
2,611.09
3,749.00
-1,137.91
-30.35%
Profit Before Tax
6,013.10
7,981.00
-1,967.90
-24.66%
Tax
1,148.51
2,420.00
-1,271.49
-52.54%
Provisions and contingencies
0
0
0.00
Profit After Tax
4,924.85
5,004.00
-79.15
-1.58%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
4,924.85
5,004.00
-79.15
-1.58%
Share in Profit of Associates
0
0
0.00
Minority Interest
-60.26
557.00
-617.26
-110.82%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
4,864.59
5,561.00
-696.41
-12.52%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
40,022.74
67,631.00
-27,608.26
-40.82%
Earnings per share (EPS)
118.30
316.43
-198.13
-62.61%
Diluted Earnings per share
118.30
316.43
-198.13
-62.61%
Operating Profit Margin (Excl OI)
9.21%
6.12%
0.00
3.09%
Gross Profit Margin
26.61%
10.17%
0.00
16.44%
PAT Margin
15.19%
4.34%
0.00
10.85%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 3,241.38 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 22.55% vs 5.42% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 486.46 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is -11.84% vs -8.81% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 559.63 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is -7.20% vs -11.91% in Mar 2024
Annual - Interest
Interest 20.27 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 46.04% vs 10.95% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 9.21%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has fallen from Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
